VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
EHC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
EHCEncompass Health Corporation
$122.21$12.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEHCQuarterly Financials

Encompass Health Corporation (EHC) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Encompass Health Corporation (EHC) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

EHC Income Statement

Quarterly statement

EHC Income Statement

Encompass Health Corporation (EHC) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue1.6B1.59B1.54B1.48B1.46B1.46B1.41B1.35B1.3B1.32B1.25B1.21B1.19B1.16B1.14B1.09B1.06B1.06B1.32B1.01B
Revenue Growth %9.58%9.01%9.94%9.36%12.03%10.59%12.69%11.94%9.61%13.41%9.63%10.78%11.73%9.54%-13.76%7.79%-17.49%-13.91%8.59%-13.89%
Cost of Goods Sold0818.1M64.5M784.8M830.8M824.5M819.1M792.7M758.1M770.1M734.9M712.5M688.2M682.8M53.9M51.1M47.3M49.8M54.2M46.7M
COGS % of Revenue-51.56%4.18%53.12%56.99%56.65%58.3%58.68%58.26%58.52%58.94%59.04%57.97%58.84%4.74%4.69%4.45%4.7%4.11%4.62%
Gross Profit1.6B768.5M1.48B692.7M626.9M630.9M585.9M558.3M543.1M545.9M511.9M494.4M498.9M477.6M1.08B1.04B1.02B1.01B1.26B964.1M
Gross Margin %100%48.44%95.82%46.88%43.01%43.35%41.7%41.32%41.74%41.48%41.06%40.96%42.03%41.16%95.26%95.31%95.55%95.3%95.89%95.38%
Gross Profit Growth %154.81%21.81%152.62%24.07%15.43%15.57%14.46%12.92%8.86%14.3%-52.75%-52.39%-50.86%-52.69%-14.32%7.71%-17.98%-14.34%8.76%-14.03%
Operating Expenses1.31B466.9M1.2B449.1M367.8M363.9M353.6M349.2M327.5M338.4M67.1M64M69.7M57.2M903.7M890M865.7M856.9M1.08B797.3M
OpEx % of Revenue81.95%29.43%77.48%30.4%25.23%25%25.17%25.85%25.17%25.71%5.38%5.3%5.87%4.93%79.46%81.69%81.48%80.89%82.22%78.88%
Selling, General & Admin62.6M58.2M884M56.1M74.1M67.2M69.2M68.4M64.7M64.2M67.1M64M69.7M57.2M670.3M655.9M635.9M640.2M841.6M590.4M
SG&A % of Revenue3.92%3.67%57.23%3.8%5.08%4.62%4.93%5.06%4.97%4.88%5.38%5.3%5.87%4.93%58.94%60.2%59.85%60.44%63.82%58.41%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K00001000K1000K1000K1000K1000K1000K
Operating Income288.4M301.6M283.4M243.6M259.1M267M232.3M209.1M215.6M207.5M444.8M430.4M429.2M420.4M179.7M148.4M149.5M152.6M180.3M166.8M
Operating Margin %18.05%19.01%18.35%16.49%17.77%18.35%16.53%15.48%16.57%15.77%35.68%35.66%36.16%36.23%15.8%13.62%14.07%14.41%13.67%16.5%
Operating Income Growth %11.31%12.96%22%16.5%20.18%28.67%-47.77%-51.42%-49.77%-50.64%147.52%190.03%187.09%175.49%-0.33%-11.03%-31.74%-26.53%-6.58%-3.3%
EBITDA378.8M388.9M369.8M326M339M346.2M310.3M287.5M288.5M277.8M514.9M497.7M501.8M484.3M243M210.5M210M210.3M246.1M222.3M
EBITDA Margin %23.71%24.51%23.94%22.06%23.26%23.79%22.09%21.28%22.17%21.11%41.3%41.24%42.27%41.74%21.37%19.32%19.76%19.85%18.66%21.99%
EBITDA Growth %11.74%12.33%19.18%13.39%17.5%24.62%-39.74%-42.23%-42.51%-42.64%111.89%136.44%138.95%130.29%-1.26%-5.31%-25.64%-22.17%-3.6%-4.88%
D&A (Non-Cash Add-back)90.4M87.3M86.4M82.4M79.9M79.2M78M78.4M72.9M70.3M70.1M67.3M72.6M63.9M63.3M62.1M60.5M57.7M65.8M55.5M
EBIT294.4M320.5M287.9M250.7M267.2M270.4M234.4M218.7M220.3M213.6M189.9M179.4M183.9M178.6M188.4M145.5M143M149.6M187.3M168.2M
Net Interest Income-32.8M-31.8M-30.2M-30.8M-30.4M-31.8M-33M-34.9M-34.3M-35.2M-34.9M-35.9M-36.3M-36.4M-37.5M-38.2M-60.4M-39.6M-40.1M-39.9M
Interest Income00000000000000000000
Interest Expense32.8M31.8M30.2M30.8M30.4M31.8M33M34.9M34.3M35.2M34.9M35.9M36.3M36.4M37.5M38.2M60.4M39.6M40.1M39.9M
Other Income/Expense-26.8M-12.9M-25.7M-23.7M-22.3M-28.4M-30.9M-25.3M-29.6M-29.1M-280M-285.4M-278M-274.2M-28.8M-41.1M-66.9M-42.6M-33.1M-38.5M
Pretax Income261.6M288.7M257.7M219.9M236.8M238.6M201.4M183.8M186M178.4M164.8M145M151.2M146.2M150.9M107.3M82.6M110M147.2M128.3M
Pretax Margin %16.38%18.2%16.68%14.88%16.24%16.39%14.33%13.6%14.29%13.56%13.22%12.01%12.74%12.6%13.27%9.85%7.77%10.38%11.16%12.69%
Income Tax53.6M56.4M55.4M44.9M51M41.6M37.6M36M38.3M38.3M37.2M30.3M32.8M31.9M31.9M21.8M22.8M23.6M31.5M26.2M
Effective Tax Rate %20.49%19.54%21.5%20.42%21.54%17.44%18.67%19.59%20.59%21.47%22.57%20.9%21.69%21.82%21.14%20.32%27.6%21.45%21.4%20.42%
Net Income153.9M194.5M146.1M126.5M142.1M151.5M120.9M108.2M114.1M112.5M87.6M85.3M91.4M87.7M89.4M45.4M48.7M87.5M91.6M100M
Net Margin %9.63%12.26%9.46%8.56%9.75%10.41%8.61%8.01%8.77%8.55%7.03%7.07%7.7%7.56%7.86%4.17%4.58%8.26%6.95%9.89%
Net Income Growth %8.3%28.38%20.84%16.91%24.54%34.67%38.01%26.85%24.84%28.28%-2.01%87.89%87.68%0.23%-2.4%-54.6%-57.02%-18.45%6.51%28.7%
Net Income (Continuing)208M232.3M202.3M175M185.8M197M163.8M147.8M147.7M140.1M127.6M114.7M118.4M114.3M119M85.5M59.8M86.4M115.7M102.1M
Discontinued Operations-600K1000K800K-400K-900K-500K400K-700K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K1000K1000K01000K
Minority Interest863.4M845.5M837.6M812.5M808.1M778.5M782.2M765.8M690.6M661.5M649.7M628.8M581.7M579.7M551.6M530.8M541.6M518.1M487.9M450.8M
EPS (Diluted)1.541.931.431.241.391.481.181.061.121.100.860.840.900.870.880.450.490.870.911.00
EPS Growth %10.79%30.41%21.19%16.98%24.11%34.55%37.21%26.19%24.44%26.44%-2.27%86.67%83.67%0%-3.3%-55%-56.64%-18.69%5.81%28.21%
EPS (Basic)1.551.961.451.261.411.501.201.081.131.120.880.860.910.880.900.450.490.880.921.00
Diluted Shares Outstanding100M100.6M102M102.3M102.2M102.1M102.3M102.1M102M102.2M101.5M101.4M101.1M100.9M100.8M100.5M100.3M100.2M100.2M100.2M
Basic Shares Outstanding98.8M99.2M100.2M100.5M100.6M100.5M100M99.9M99.9M99.8M99.5M99.5M99.5M99.4M99.3M99.2M99.2M99.2M99M99M
Dividend Payout Ratio12.28%10.44%13%13.44%12.03%11.88%14.06%13.86%13.06%14.13%17.01%17.59%16.3%17.79%16.67%61.23%57.08%32.57%30.24%27.6%